• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

长期霍奇金淋巴瘤幸存者的后续恶性肿瘤和心血管疾病负担高。

High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors.

机构信息

Department of Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

Department of Hematology, Erasmus MC Cancer Institute, Wytemaweg 80, Rotterdam 3015 CN, The Netherlands.

出版信息

Br J Cancer. 2018 Mar 20;118(6):887-895. doi: 10.1038/bjc.2017.476. Epub 2018 Jan 30.

DOI:10.1038/bjc.2017.476
PMID:29381685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5886118/
Abstract

This corrects the article DOI: 10.1038/bjc.2017.85.

摘要

该文的 DOI 需要更正：10.1038/bjc.2017.85。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb3/5886118/a2b36870aa75/bjc2017476f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb3/5886118/05dc8484d468/bjc2017476f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb3/5886118/63236329522a/bjc2017476f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb3/5886118/6cccded5aa7e/bjc2017476f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb3/5886118/a2b36870aa75/bjc2017476f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb3/5886118/05dc8484d468/bjc2017476f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb3/5886118/63236329522a/bjc2017476f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb3/5886118/6cccded5aa7e/bjc2017476f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb3/5886118/a2b36870aa75/bjc2017476f4.jpg

相似文献

1
High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors.长期霍奇金淋巴瘤幸存者的后续恶性肿瘤和心血管疾病负担高。
Br J Cancer. 2018 Mar 20;118(6):887-895. doi: 10.1038/bjc.2017.476. Epub 2018 Jan 30.
2
Association of Treatment for Hodgkin Lymphoma With Estrogen Receptor Status of Subsequent Breast Cancers.霍奇金淋巴瘤治疗与后续乳腺癌雌激素受体状态的关联。
JAMA Oncol. 2018 Mar 1;4(3):414-416. doi: 10.1001/jamaoncol.2017.4887.
3
Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.霍奇金淋巴瘤长期幸存者的发病率和死亡率：来自儿童癌症幸存者研究的报告。
Blood. 2011 Feb 10;117(6):1806-16. doi: 10.1182/blood-2010-04-278796. Epub 2010 Oct 29.
4
Second cancer risk for Hodgkin's lymphoma survivors.霍奇金淋巴瘤幸存者的二次患癌风险。
Lancet Oncol. 2016 Feb;17(2):e50. doi: 10.1016/S1470-2045(16)00002-4. Epub 2016 Jan 8.
5
Late morbidity and mortality in patients with Hodgkin's lymphoma treated during adulthood.成年期接受治疗的霍奇金淋巴瘤患者的晚期发病率和死亡率。
J Natl Cancer Inst. 2015 Feb 24;107(4). doi: 10.1093/jnci/djv018. Print 2015 Apr.
6
Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma: influence on long-term adverse effects (SOPHIA).霍奇金淋巴瘤女性幸存者原发性卵巢功能不全队列研究的基本原理与设计：对长期不良反应的影响（SOPHIA研究）
BMJ Open. 2018 Sep 11;8(9):e018120. doi: 10.1136/bmjopen-2017-018120.
7
Cardiovascular Disease Risk After Treatment-Induced Premature Ovarian Insufficiency in Female Survivors of Hodgkin Lymphoma.霍奇金淋巴瘤女性幸存者治疗引起的卵巢早衰后的心血管疾病风险
J Am Coll Cardiol. 2018 Dec 25;72(25):3374-3375. doi: 10.1016/j.jacc.2018.10.030.
8
Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).霍奇金淋巴瘤和非霍奇金淋巴瘤长期幸存者的后续恶性肿瘤：德国癌症登记数据的汇总分析（1990-2012 年）。
Br J Haematol. 2017 Apr;177(2):226-242. doi: 10.1111/bjh.14530. Epub 2017 Jan 20.
9
[Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].睾丸癌和霍奇金淋巴瘤治疗后的长期并发症
Ned Tijdschr Geneeskd. 2010;154(45):A2229.
10
Excess mortality among 10-year survivors of classical Hodgkin lymphoma in adolescents and young adults.青少年和年轻成人中经典型霍奇金淋巴瘤 10 年幸存者的超额死亡率。
Am J Hematol. 2018 Feb;93(2):238-245. doi: 10.1002/ajh.24964. Epub 2017 Nov 21.

引用本文的文献

1
Cardiovascular Disease Mortality Risk among Long-term Survivors of Different Hodgkin Lymphoma Types.不同类型霍奇金淋巴瘤长期幸存者的心血管疾病死亡风险
Rev Cardiovasc Med. 2025 Jun 30;26(6):24981. doi: 10.31083/RCM24981. eCollection 2025 Jun.
2
Distressed personality is associated with late adverse effects in long-term survivors of Hodgkin lymphoma.苦恼型人格与霍奇金淋巴瘤长期幸存者的晚期不良影响有关。
Acta Oncol. 2024 Aug 4;63:600-606. doi: 10.2340/1651-226X.2024.40312.
3
Cardiovascular screening outcomes in the Dutch survivorship care program for Hodgkin lymphoma survivors.

本文引用的文献

1
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.早期正电子发射断层扫描反应适应性治疗 I 期和 II 期霍奇金淋巴瘤：随机 EORTC/LYSA/FIL H10 试验的最终结果。
J Clin Oncol. 2017 Jun 1;35(16):1786-1794. doi: 10.1200/JCO.2016.68.6394. Epub 2017 Mar 14.
2
Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.霍奇金淋巴瘤儿童、青少年及年轻成人幸存者心血管疾病发病的累积负担：来自圣裘德终身队列研究的分析
Lancet Oncol. 2016 Sep;17(9):1325-34. doi: 10.1016/S1470-2045(16)30215-7. Epub 2016 Jul 25.
3
荷兰霍奇金淋巴瘤幸存者生存护理计划中的心血管筛查结果。
J Cancer Surviv. 2024 Apr 23. doi: 10.1007/s11764-024-01561-y.
4
Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design.霍奇金淋巴瘤幸存者的生存护理的有效性和成本效益（INSIGHT研究）：一项采用准实验设计的多中心回顾性队列研究方案
JMIR Res Protoc. 2024 Apr 18;13:e55601. doi: 10.2196/55601.
5
Long-term second primary cancer risk in adolescent and young adult (15-39 years) cancer survivors: a population-based study in the Netherlands between 1989 and 2018.青少年和年轻成人（15-39 岁）癌症幸存者的长期第二原发癌风险：1989 年至 2018 年荷兰基于人群的研究。
ESMO Open. 2024 Jan;9(1):102203. doi: 10.1016/j.esmoop.2023.102203. Epub 2024 Jan 2.
6
Challenges and Opportunities of Epidemiological Studies to Reduce the Burden of Cancers in Young Adults.减少青年成人癌症负担的流行病学研究的挑战与机遇
Curr Epidemiol Rep. 2023 Sep;10(3):115-124. doi: 10.1007/s40471-022-00286-9. Epub 2022 Mar 29.
7
Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies.超越最高级别：为血液恶性肿瘤不良事件的评估和报告现代化而取得的进展和未来方向。
Lancet Haematol. 2022 May;9(5):e374-e384. doi: 10.1016/S2352-3026(22)00045-X.
8
Late relapses in Hodgkin lymphoma - should we search for the needle in the haystack?霍奇金淋巴瘤的迟发性复发——我们是否应该大海捞针？
Br J Haematol. 2022 Jul;198(1):11-13. doi: 10.1111/bjh.18199. Epub 2022 Apr 19.
9
Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016.2000-2016 年基于人群的经典霍奇金淋巴瘤患者初始化疗后的病因特异性死亡率。
J Clin Oncol. 2020 Dec 10;38(35):4149-4162. doi: 10.1200/JCO.20.00264. Epub 2020 Sep 18.
10
Effect of radiotherapy on the expression of cardiovascular disease-related miRNA-146a, -155, -221 and -222 in blood of women with breast cancer.放疗对乳腺癌女性血液中心血管疾病相关 miRNA-146a、-155、-221 和 -222 表达的影响。
PLoS One. 2019 May 31;14(5):e0217443. doi: 10.1371/journal.pone.0217443. eCollection 2019.
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
霍奇金淋巴瘤治疗后 40 年内的二次癌症风险。
N Engl J Med. 2015 Dec 24;373(26):2499-511. doi: 10.1056/NEJMoa1505949.
4
Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.霍奇金淋巴瘤治疗后的心血管疾病：40 年疾病风险。
JAMA Intern Med. 2015 Jun;175(6):1007-17. doi: 10.1001/jamainternmed.2015.1180.
5
Risk of valvular heart disease after treatment for Hodgkin lymphoma.霍奇金淋巴瘤治疗后发生心脏瓣膜病的风险。
J Natl Cancer Inst. 2015 Feb 23;107(4). doi: 10.1093/jnci/djv008. Print 2015 Apr.
6
Estimating the burden of recurrent events in the presence of competing risks: the method of mean cumulative count.在存在竞争风险的情况下估计复发事件的负担：平均累积计数法。
Am J Epidemiol. 2015 Apr 1;181(7):532-40. doi: 10.1093/aje/kwu289. Epub 2015 Feb 17.
7
Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group.早期霍奇金淋巴瘤的放射治疗计划：国际淋巴瘤放射肿瘤学组的经验
Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):144-52. doi: 10.1016/j.ijrobp.2014.12.009. Epub 2015 Feb 7.
8
Prospective phase II trial of image-guided radiotherapy in Hodgkin lymphoma: benefit of deep inspiration breath-hold.霍奇金淋巴瘤图像引导放射治疗的前瞻性II期试验：深吸气屏气的益处
Acta Oncol. 2015 Jan;54(1):60-6. doi: 10.3109/0284186X.2014.932435. Epub 2014 Jul 15.
9
Risk of multiple primary malignancies following treatment of Hodgkin lymphoma.霍奇金淋巴瘤治疗后的多原发性恶性肿瘤风险。
Blood. 2014 Jul 17;124(3):319-27; quiz 466. doi: 10.1182/blood-2013-10-532184. Epub 2014 Apr 16.
10
Stomach cancer risk after treatment for hodgkin lymphoma.霍奇金淋巴瘤治疗后的胃癌风险。
J Clin Oncol. 2013 Sep 20;31(27):3369-77. doi: 10.1200/JCO.2013.50.6832. Epub 2013 Aug 26.